We are live on ! Find out more
Zurich Cantonal Bank

Zurich Cantonal Bank Portfolio holdings

AUM $46B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
-2.82%
1 Year Est. Return
+27.59%
3 Year Est. Return
+97.89%
5 Year Est. Return
+132.69%
10 Year Est. Return
+500.34%
AUM
$20.3B
AUM Growth
-$365M
Cap. Flow
+$648M
Cap. Flow %
3.19%
Top 10 Hldgs %
26.97%
Holding
2,921
New
57
Increased
957
Reduced
718
Closed
195

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$81.9M
2
CSCO icon
Cisco
CSCO
+$60.5M
3
ATKR icon
Atkore
ATKR
+$43M
4
BNS icon
Scotiabank
BNS
+$40.3M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$38M

Top Sells

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$50.9M
2
SIVB
SVB Financial Group
SIVB
+$35.9M
3
TMUS icon
T-Mobile US
TMUS
+$33.6M
4
APTV icon
Aptiv
APTV
+$28M
5
XLNX
Xilinx Inc
XLNX
+$26.9M

Sector Composition

Rank Sector Weight
1 Technology 25.3%
2 Financials 15.57%
3 Healthcare 14.62%
4 Consumer Discretionary 10.14%
5 Industrials 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AQB icon
2551
AquaBounty Technologies
AQB
$7.67M
$33K ﹤0.01%
887
-10
-1% -$348
WTTR icon
2552
Select Water Solutions
WTTR
$2.72B
$33K ﹤0.01%
3,845
LONA
2553
LeonaBio Inc
LONA
$71.6M
$32K ﹤0.01%
+238
New +$25.1K
FDMT icon
2554
4D Molecular Therapeutics
FDMT
$601M
$32K ﹤0.01%
2,114
SNY icon
2555
Sanofi
SNY
$104B
$32K ﹤0.01%
+619
New +$32K
AD
2556
Array Digital Infrastructure
AD
$3.02B
$32K ﹤0.01%
1,060
CGEN icon
2557
Compugen
CGEN
$227M
$31K ﹤0.01%
9,556
KZR
2558
DELISTED
Kezar Life Sciences
KZR
$31K ﹤0.01%
187
-371
-66% -$53.2K
SRRK icon
2559
Scholar Rock
SRRK
$6.35B
$31K ﹤0.01%
2,419
-1,170
-33% -$20K
KDNY
2560
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$31K ﹤0.01%
+1,923
New +$26.1K
BVS icon
2561
Bioventus
BVS
$1.17B
$30K ﹤0.01%
+2,139
New +$28.6K
CLW icon
2562
Clearwater Paper
CLW
$365M
$30K ﹤0.01%
1,073
EYPT icon
2563
EyePoint Inc
EYPT
$1.12B
$30K ﹤0.01%
+2,505
New +$27.5K
KODK icon
2564
Kodak
KODK
$987M
$30K ﹤0.01%
4,524
ARQT icon
2565
Arcutis Biotherapeutics
ARQT
$3.3B
$29K ﹤0.01%
+1,494
New +$25.3K
CIBR icon
2566
First Trust NASDAQ Cybersecurity ETF
CIBR
$15.6B
$29K ﹤0.01%
553
EHTH icon
2567
eHealth
EHTH
$39.4M
$29K ﹤0.01%
2,321
KROS icon
2568
Keros Therapeutics
KROS
$211M
$29K ﹤0.01%
530
-254
-32% -$13K
MRSN
2569
DELISTED
Mersana Therapeutics
MRSN
$29K ﹤0.01%
290
-103
-26% -$12K
RBBN icon
2570
Ribbon Communications
RBBN
$356M
$29K ﹤0.01%
9,296
REVG
2571
DELISTED
REV Group
REVG
$29K ﹤0.01%
2,156
CCF
2572
DELISTED
Chase Corporation
CCF
$29K ﹤0.01%
332
ALX
2573
Alexander's
ALX
$1.39B
$28K ﹤0.01%
108
HACK icon
2574
Amplify Cybersecurity ETF
HACK
$3B
$28K ﹤0.01%
470
ITRN icon
2575
Ituran Location and Control
ITRN
$1.04B
$28K ﹤0.01%
1,222

Similar funds

Zurich Cantonal Bank's Q1 2022 Portfolio in Review

As of Q1 2022, Zurich Cantonal Bank held 2,921 positions worth $20.3B, down 1.8% from $20.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Zurich Cantonal Bank deployed $648M of net new capital in Q1 2022, opening 57 new positions and adding to 957 existing holdings. Its largest new stake was Amplify Travel Tech ETF: 21,900 shares worth $523K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was UBS Group, an estimated $50.9M trimmed.

  • Zurich Cantonal Bank's largest Q1 2022 buy was Amplify Travel Tech ETF: 21,900 shares worth $523K.
  • Zurich Cantonal Bank added most to Verizon in Q1 2022, an estimated $81.9M increase.
  • Zurich Cantonal Bank's biggest Q1 2022 reduction was UBS Group, cutting an estimated $50.9M.
  • Zurich Cantonal Bank fully exited Xilinx Inc in Q1 2022, selling an estimated $26.9M.
  • Zurich Cantonal Bank's ten largest holdings make up 27% of its $20.3B portfolio in Q1 2022.
  • Zurich Cantonal Bank opened 57 new positions and closed 195 in Q1 2022.
  • Zurich Cantonal Bank's portfolio value fell 1.8% quarter-over-quarter to $20.3B.

Based on Zurich Cantonal Bank's 13F filing for Q1 2022, filed 21 Apr 2022.